<script class="panel-body" id="ExChip_SIGMA1_script" type="x-tmpl-mustache">
<h6 style="color:#ccc;">Data set phenotypes</h6>
<ul>
    <li><g:message code="informational.shared.traits.t2d"></g:message></li>
</ul>


    <h4>Dataset subjects</h4>

    <table class="table table-condensed table-responsive table-striped">
        <tr><th>Cases</th><th>Controls</th><th>Cohort</th><th>Ancestry</th></tr>

        <tr><td>815</td><td>1138</td><td><a onclick="showSection(event)">UNAM/INCMNSZ Diabetes Study (UIDS)</a>

            <div style="display: none;" class="cohortDetail">
                <table border="1">
                    <tr><th>Case selection criteria</th><th>Control selection criteria</th></tr>
                    <tr>
                        <td valign="top">
                            <ul>
                                <li>ADA criteria: fasting plasma glucose values &ge;126 mg/dL, current treatment with a hypoglycemic agent, or casual glucose values &ge;200 mg/dL</li>
                            </ul>
                        </td>
                        <td valign="top">
                            <ul>
                                <li>Age &ge;45 years</li>
                                <li>fasting plasma glucose concentration &lt; 100 mg/dl</li>
                                <li>no previous history of hyperglycemia, gestational diabetes or use of metformin</li>
                            </ul>
                        </td></tr>

                </table>
            </div></td><td>Latino</td></tr>

        <tr><td>690</td><td>472</td><td><a onclick="showSection(event)">Diabetes in Mexico Study (DMS)</a>

            <div style="display: none;" class="cohortDetail">
                <table border="1">
                    <tr><th>Case selection criteria</th><th>Control selection criteria</th></tr>
                    <tr>
                        <td valign="top">
                            <ul>
                                <li>Age &ge;18 years</li>
                                <li>previous T2D diagnosis or fasting glucose levels above 125 mg/dL</li>
                                <li>excluded individuals with fasting glycemia between 100-125 mg/dL</li>
                            </ul>
                        </td>
                        <td valign="top">
                            <ul>
                                <li>Age &ge;45 years</li>
                                <li>fasting glucose levels below 100 mg/dL</li>
                            </ul>
                        </td></tr>
                </table>
            </div></td><td>Latino</td></tr>

        <tr><td>287</td><td>613</td><td><a onclick="showSection(event)">Mexico City Diabetes Study (MCDS)</a>

            <div style="display: none;" class="cohortDetail">
                <table border="1">
                    <tr><th>Case selection criteria</th><th>Control selection criteria</th></tr>
                    <tr>
                        <td valign="top">
                            <ul>
                                <li>age 35-64 years</li>
                                <li>non-pregnant females</li>
                                <li>T2D diagnosis and medication OR ADA criteria: Fasting glucose 126 mg/dL or more or 2 hr post 75 gr of glucose load 200 or more</li>
                            </ul>
                        </td>
                        <td valign="top">
                            <ul>
                                <li>age 35-64 years</li>
                                <li>non-pregnant females</li></ul>
                        </td></tr>

                </table>
            </div></td><td>Latino</td></tr>

        <tr><td>2056</td><td>2143</td><td><a onclick="showSection(event)">Multiethnic Cohort (MEC)</a>

            <div style="display: none;" class="cohortDetail">
                <table border="1">
                    <tr><th>Case selection criteria</th><th>Control selection criteria</th></tr>
                    <tr>
                        <td valign="top">
                            <ul>
                                <li>self-report of T2D diagnosis or medication</li>
                                <li>absence of T1D diagnosis</li>
                            </ul>
                        </td>
                        <td valign="top">
                            <ul>
                                <li>no self-report of T2D diagnosis or medication</li>
                                <li>no T1D or T2D diagnosis from the OSHPD, HMSA or KPH registries</li>
                                <ul>
                        </td></tr>

                </table>
            </div></td><td>Latino</td></tr>

        <tr><td>Total: 3,848</td><td>Total: 4,366</td><td></td><td></td></tr>
    </table>
    <h6 style="color:#ccc;">Project</h6>
    <h4>Slim Initiative in Genomic Medicine for the Americas (SIGMA) <small><a
            href="http://www.type2diabetesgenetics.org/projects/sigma" target="_blank">Learn more ></a>
    </small></h4>

    <p>The SIGMA partnership aims to understand the genomic basis of type 2 diabetes in Mexican and Latin American populations.</p>

</div>
</script>